Skip To Main Content
Monica Barratt on Muck Rack

Monica Barratt

Castlemaine
As seen in: Color Research & Application, Wiley, Wiley Online Library, ABC News (Australia), Harm Reduction Journal, Memory Studies, Stuff.co.nz, Sydney Morning Herald, Taylor & Francis Online, The Conversation and
Drug policy, social in/equity & networked societies. Academic @SGSC_RMIT @DigitalEthno @NDARCNEWS also with @GlobalDrugSurvy @WeAreTheLoopAU @BluelightForum
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Monica

Contact Monica, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Non-Prescribed Gabapentinoid Use: Demographic and Behavioural Risk Profiles in a Large International Sample

|
By Jennifer Seddon, Monica Barratt, Cheneal Puljevic
| Wiley Online Library Verified
1 Introduction Gabapentinoids (i.e., pregabalin and gabapentin) are medications used to treat epilepsy and neuropathic pain, with pregabalin also approved for the treatment of generalised anxiety disorder in Europe and fibromyalgia in the United States [1].
Open in Who Shared Issue with article?

Price of Nitazenes for Sale on Cryptomarkets and Surface Web Shops

|
By Nicola Man, Monica Barratt, Raimondo Bruno
| Wiley Online Library Verified
1 Introduction Nitazenes are a class of synthetic 2-benzyl benzimidazole opioids, originally developed as analgesics but never approved for clinical use due to their high-risk profile [1]. While similar in effect to morphine, some nitazene compounds exhibit markedly greater potency [2, 3]. For example, metonitazene has demonstrated potency comparable to fentanyl and other nitazenes (e.g., protonitazene, isotonitazene and etonitazene) have shown even greater potency.
Open in Who Shared Issue with article?

“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice

|
By Stephen Bright, Monica Barratt, Jordan J. Negrine
| Taylor & Francis Online
Abstract Background Following Australia’s landmark 2023 decision to approve psilocybin and MDMA for clinical use, psychedelic-assisted therapy (PAT) is beginning to emerge within regulated mental health settings. This study investigates psychologists’ views on the relevance of psychedelic therapists’ lived-living experience (LLE) with psychedelics. While discussion around LLE is growing, little is known about how psychologists perceive its role in clinical preparedness for PAT.
Open in Who Shared Issue with article?
See all 50 licensed articles (56 Total)